D

Diagnos Laboratorium Utama PT Tbk
IDX:DGNS

Watchlist Manager
Diagnos Laboratorium Utama PT Tbk
IDX:DGNS
Watchlist
Price: 230 IDR Market Closed
Market Cap: 287.5B IDR
Have any thoughts about
Diagnos Laboratorium Utama PT Tbk?
Write Note

Intrinsic Value

The intrinsic value of one DGNS stock under the Base Case scenario is 254.41 IDR. Compared to the current market price of 230 IDR, Diagnos Laboratorium Utama PT Tbk is Undervalued by 10%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

DGNS Intrinsic Value
254.41 IDR
Undervaluation 10%
Intrinsic Value
Price
D
Worst Case
Base Case
Best Case

Valuation Backtest
Diagnos Laboratorium Utama PT Tbk

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for DGNS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about DGNS?
Bearish
Neutral
Bullish

Fundamental Analysis

Economic Moat
Diagnos Laboratorium Utama PT Tbk

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Diagnos Laboratorium Utama PT Tbk

Provide an overview of the primary business activities
of Diagnos Laboratorium Utama PT Tbk.

What unique competitive advantages
does Diagnos Laboratorium Utama PT Tbk hold over its rivals?

What risks and challenges
does Diagnos Laboratorium Utama PT Tbk face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Diagnos Laboratorium Utama PT Tbk.

Provide P/S
for Diagnos Laboratorium Utama PT Tbk.

Provide P/E
for Diagnos Laboratorium Utama PT Tbk.

Provide P/OCF
for Diagnos Laboratorium Utama PT Tbk.

Provide P/FCFE
for Diagnos Laboratorium Utama PT Tbk.

Provide P/B
for Diagnos Laboratorium Utama PT Tbk.

Provide EV/S
for Diagnos Laboratorium Utama PT Tbk.

Provide EV/GP
for Diagnos Laboratorium Utama PT Tbk.

Provide EV/EBITDA
for Diagnos Laboratorium Utama PT Tbk.

Provide EV/EBIT
for Diagnos Laboratorium Utama PT Tbk.

Provide EV/OCF
for Diagnos Laboratorium Utama PT Tbk.

Provide EV/FCFF
for Diagnos Laboratorium Utama PT Tbk.

Provide EV/IC
for Diagnos Laboratorium Utama PT Tbk.

Compare the intrinsic valuations
of Diagnos Laboratorium Utama PT Tbk and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Diagnos Laboratorium Utama PT Tbk against its competitors.

Analyze the profit margins
(gross, operating, and net) of Diagnos Laboratorium Utama PT Tbk compared to its peers.

Compare the P/E ratios
of Diagnos Laboratorium Utama PT Tbk against its peers.

Discuss the investment returns and shareholder value creation
comparing Diagnos Laboratorium Utama PT Tbk with its peers.

Analyze the financial leverage
of Diagnos Laboratorium Utama PT Tbk compared to its main competitors.

Show all profitability ratios
for Diagnos Laboratorium Utama PT Tbk.

Provide ROE
for Diagnos Laboratorium Utama PT Tbk.

Provide ROA
for Diagnos Laboratorium Utama PT Tbk.

Provide ROIC
for Diagnos Laboratorium Utama PT Tbk.

Provide ROCE
for Diagnos Laboratorium Utama PT Tbk.

Provide Gross Margin
for Diagnos Laboratorium Utama PT Tbk.

Provide Operating Margin
for Diagnos Laboratorium Utama PT Tbk.

Provide Net Margin
for Diagnos Laboratorium Utama PT Tbk.

Provide FCF Margin
for Diagnos Laboratorium Utama PT Tbk.

Show all solvency ratios
for Diagnos Laboratorium Utama PT Tbk.

Provide D/E Ratio
for Diagnos Laboratorium Utama PT Tbk.

Provide D/A Ratio
for Diagnos Laboratorium Utama PT Tbk.

Provide Interest Coverage Ratio
for Diagnos Laboratorium Utama PT Tbk.

Provide Altman Z-Score Ratio
for Diagnos Laboratorium Utama PT Tbk.

Provide Quick Ratio
for Diagnos Laboratorium Utama PT Tbk.

Provide Current Ratio
for Diagnos Laboratorium Utama PT Tbk.

Provide Cash Ratio
for Diagnos Laboratorium Utama PT Tbk.

What is the historical Revenue growth
over the last 5 years for Diagnos Laboratorium Utama PT Tbk?

What is the historical Net Income growth
over the last 5 years for Diagnos Laboratorium Utama PT Tbk?

What is the current Free Cash Flow
of Diagnos Laboratorium Utama PT Tbk?

Discuss the annual earnings per share (EPS)
trend over the past five years for Diagnos Laboratorium Utama PT Tbk.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Diagnos Laboratorium Utama PT Tbk

Current Assets 95.6B
Cash & Short-Term Investments 9.7B
Receivables 50.6B
Other Current Assets 35.3B
Non-Current Assets 194.8B
Long-Term Investments 13B
PP&E 174.4B
Intangibles 1.3B
Other Non-Current Assets 6.1B
Current Liabilities 28.3B
Accounts Payable 11.6B
Accrued Liabilities 2.7B
Other Current Liabilities 14B
Non-Current Liabilities 65.6B
Long-Term Debt 62.9B
Other Non-Current Liabilities 2.7B
Efficiency

Earnings Waterfall
Diagnos Laboratorium Utama PT Tbk

Revenue
155.5B IDR
Cost of Revenue
-88.2B IDR
Gross Profit
67.3B IDR
Operating Expenses
-73B IDR
Operating Income
-5.7B IDR
Other Expenses
965.1m IDR
Net Income
-4.8B IDR

Free Cash Flow Analysis
Diagnos Laboratorium Utama PT Tbk

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

DGNS Profitability Score
Profitability Due Diligence

Diagnos Laboratorium Utama PT Tbk's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive 3-Year Average ROE
Negative Operating Income
41/100
Profitability
Score

Diagnos Laboratorium Utama PT Tbk's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

DGNS Solvency Score
Solvency Due Diligence

Diagnos Laboratorium Utama PT Tbk's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Average Altman Z-Score
62/100
Solvency
Score

Diagnos Laboratorium Utama PT Tbk's solvency score is 62/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

DGNS Price Targets Summary
Diagnos Laboratorium Utama PT Tbk

There are no price targets for DGNS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for DGNS?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for DGNS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Diagnos Laboratorium Utama PT Tbk

Country

Indonesia

Industry

Health Care

Market Cap

287.5B IDR

Dividend Yield

0%

Description

PT Diagnos Laboratorium Utama Tbk engages in the provision of health support service. The company employs 54 full-time employees The company went IPO on 2021-01-15. The firm is engaged in providing health support services, such as health laboratories, other diagnostic drawing centers, blood testing laboratories, pharmaceutical warehouses, eye banks, sperm banks and blood banks, organ transplant banks, and other medical support services. The company operates through providing health services using laboratories segment. The Company’s products and services include clinical pathology laboratory, anatomy pathology laboratory, genomic laboratory, homecare health services, corporate health services, and Covid-19 checkup. The firm serves markets, such as Jakarta, Depok, Bali, Bandung, Bekasi, Padang, Makassar, Tangerang Selatan, Dumai, Batam, Purwakarta, Karawang, and Brebes. The company has branch offices in Ciputat (South Tangerang), Denpasar (Bali), Padang (West Sumatra), and Makassar, South Sulawesi.

Contact

Jakartalaboratory, Jl. Teuku Cik Ditiro No.28 Central, Java
+62213193183
diagnos.co.id

IPO

2021-01-15

Employees

54

Officers

President Director
Engineer Mesha Rizal Sini
Director of Operations & Marketing and Director
Ms. Dilly Dwiasri
GM of Sales & Independent Commissioner
Mr. Martinus Eliatulo Zega
MD & Director
Mr. Fergus Richard
Head of Internal Audit Unit & Manager of SPI
Maurina Dwiyanthi
Corporate Secretary
Mr. Fanfan Riksani

See Also

Discover More
What is the Intrinsic Value of one DGNS stock?

The intrinsic value of one DGNS stock under the Base Case scenario is 254.41 IDR.

Is DGNS stock undervalued or overvalued?

Compared to the current market price of 230 IDR, Diagnos Laboratorium Utama PT Tbk is Undervalued by 10%.

Back to Top